Key result
A talin-1 mutant (W359A) that disrupts binding to the NPxY motif in β3 protected mice from experimental thrombosis without undermining hemostasis by decelerating αIIbβ3 activation.
A talin-1 mutation in mice protects against thrombosis without compromising hemostasis, suggesting a potential new target for safer antiplatelet therapy.
In this issue of Blood , Stefanini and colleagues report a new way to regulate platelet function. Mice expressing a talin-1 mutant (W359A) that disrupts its binding to the NPxY motif in β3 were protected from experimental thrombosis without undermining hemostasis by decelerating αIIbβ3 activation
No takes yet. Share an insight, caveat, or question.
Yoshiaki Tomiyama (2014) studied this question. A talin-1 mutant (W359A) that disrupts binding to the NPxY motif in β3 protected mice from experimental thrombosis without undermining hemostasis by decelerating αIIbβ3 activation.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: